BRIEF published on 08/22/2024 at 18:05, 1 month 10 days ago ABIONYX Pharma: Review of the first half of 2024 Biotechnology Fundraising Treasury Turnover ABIONYX Pharma
PRESS RELEASE published on 08/22/2024 at 18:00, 1 month 10 days ago Inside Information / Other news releases ABIONYX Pharma reports €2.4m sales and €5.3m cash position for H1 2024, focused on innovative therapies. Raised €3.4m for sepsis program in the US Sales Cash Position Innovative Therapies ABIONYX Pharma Sepsis
BRIEF published on 07/01/2024 at 09:27, 3 months ago ABIONYX Successfully Completes €3.4 Million Capital Increase Capital Increase Biotech Shares And Warrants ABIONYX Sepsis Development
PRESS RELEASE published on 07/01/2024 at 09:22, 3 months ago Inside Information / Other news releases ABIONYX successfully completes a capital increase of c.€3.4 million through the issuance of shares with warrants. The fundraising aims to strengthen the company's cash position for its development in sepsis and the United States Fundraising Capital Increase Sepsis ABIONYX Shares With Warrants
BRIEF published on 06/27/2024 at 19:27, 3 months 4 days ago ABIONYX Pharma Achieves Unanimous Approval at Combined General Meeting Shareholders Biotech General Meeting Resolutions ABIONYX Pharma
PRESS RELEASE published on 06/27/2024 at 19:22, 3 months 4 days ago Inside Information / Other news releases ABIONYX Pharma announces unanimous approval of all resolutions at its Combined General Meeting. Shareholders renew mandates and approve buyback program Shareholders Buyback Program Renewal Combined General Meeting ABIONYX Pharma
BRIEF published on 06/19/2024 at 21:20, 3 months 12 days ago ABIONYX announces a capital increase without preferential subscription rights Biotechnology Actions United States Increase In Capital Sepsis
PRESS RELEASE published on 06/19/2024 at 21:15, 3 months 12 days ago Inside Information / Other news releases ABIONYX announces capital increase of c.€3.4 million with share issuance and warrants, strengthening financial position for Sepsis and US development, supported by ORSAY 53 investment company Capital Increase Share Issuance ABIONYX Sepsis Development ORSAY 53
BRIEF published on 06/13/2024 at 19:53, 3 months 18 days ago ABIONYX Pharma Receives FDA Approval for New Sepsis Study FDA Clinical Study ABIONYX Pharma Sepsis CER-001
PRESS RELEASE published on 06/13/2024 at 19:48, 3 months 18 days ago Inside Information / Other news releases ABIONYX Pharma completes successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial in Sepsis, marking significant progress in developing innovative therapy FDA ABIONYX Pharma Sepsis CER-001 Pre-IND Meeting
Published on 10/02/2024 at 01:15, 7 hours 7 minutes ago Major Regional Aircore Drilling Program Starts at Tarcoola
Published on 10/02/2024 at 00:05, 8 hours 17 minutes ago Silver Spruce Resources Inc. Announces Share Consolidation Proposal
Published on 10/02/2024 at 00:00, 8 hours 22 minutes ago BlackBerry Appoints Lisa Bahash to its Board of Directors
Published on 10/01/2024 at 23:55, 8 hours 27 minutes ago Omar Harfouch's 'Concerto for Peace' Brings a Message of Unity to Paris
Published on 10/01/2024 at 23:07, 9 hours 15 minutes ago Justera Health Signs Definitive Agreement To Acquire Popular Cannabis Brand, Port North
Published on 10/02/2024 at 08:00, 22 minutes ago Dalata Hotel Group PLC: POS-Transaction in Own Shares
Published on 10/02/2024 at 08:00, 22 minutes ago Coinsilium Group Limited: Strategic Advisory Services Agreement with Stabolut Decentralised Yield-Generating Stablecoin
Published on 10/02/2024 at 08:00, 22 minutes ago One Heritage Group plc: Strategic Update and Market Listing
Published on 10/02/2024 at 08:00, 22 minutes ago Thrive Renewables Plc 2024 Half Year Results for the period ended 30 June 2024
Published on 10/01/2024 at 18:00, 14 hours 22 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 10/01/2024 at 18:00, 14 hours 22 minutes ago EURAZEO ANNOUNCES THE SALE OF 22 HOTELS BY GRAPE HOSPITALITY
Published on 10/01/2024 at 17:50, 14 hours 32 minutes ago First stone laid at new mechanical welding plant dedicated to the platform business
Published on 10/01/2024 at 15:30, 16 hours 52 minutes ago Lagardère and LVMH complete the sale of Paris Match - Paris Match joins the LVMH Group